Loading organizations...

Burrill Life Sciences Capital Fund III: Funding, Team & Investors | Startup Intros

Burrill Life Sciences Capital Fund III

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 25, 2015	Neos Therapeutics	$20.6M Other Equity	—	CAC, Crabtree Partners, Delaware Street Capital, Essex Capital Corporation, Presidio Partners
Mar 4, 2014	Neos Therapeutics	$15.5M Series C	—	CAC, CMEA Capital, Crabtree Partners, Delaware Street Capital
Sep 20, 2010	NewBridge Pharmaceuticals	$12.0M Series B	Qais Marafie	Victor A. Hebert

Total Raised

N/A

Valuation

N/A